From what 0 stock analysts predict, the share price for Marker Therapeutics Inc (MRKR) might increase by 324.19% in the next year. This is based on a 12-month average estimation for MRKR. Price targets go from $11 to $12.5. The majority of stock analysts believe MRKR is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assigned MRKR 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Marker Therapeutics Inc to perform worse than the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on MRKR. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of MRKR.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Aydin Huseynov Ladenburg Thalmann | Buy | $11 | Initiates | Apr 30, 2024 |
Tony Butler Roth Capital | Neutral | $1 | Downgrade | Feb 17, 2022 |
Piper Sandler | Overweight | Initiates | Mar 25, 2021 | |
Cantor Fitzgerald | Overweight | Initiates | Mar 19, 2021 | |
Cantor Fitzgerald | Overweight | Initiates | Mar 18, 2021 | |
Edward Tenthoff Piper Sandler | Neutral | $2.5 | Downgrade | May 12, 2020 |
Piper Jaffray | Overweight | Maintains | Nov 13, 2019 | |
Janney Montgomery Scott | Buy | $10 | Maintains | Nov 13, 2019 |
Piper Sandler | Overweight | $6 | Maintains | Nov 13, 2019 |
Janney Capital | Buy | Maintains | Nov 13, 2019 | |
Oppenheimer | Outperform | Initiates | Jul 3, 2019 | |
Roth Capital | Buy | Initiates | May 30, 2019 | |
WBB Securities | Strong Buy | Upgrade | Mar 29, 2019 | |
Janney Montgomery Scott | Buy | Initiates | Mar 1, 2019 | |
Janney Capital | Buy | Initiates | Mar 1, 2019 |
When did it IPO
N/A
Staff Count
8
Country
United States
Sector/Industry
Healthcare/Biotechnology
CEO
Dr. Juan F. Vera M.D.
Market Cap
$32.3M
In 2023, MRKR generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that MRKR's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
No news data available.